Opus Genetics (IRD) PT Lowered to $9 at RBC Capital
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Price: $4.76 -7.75%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on Opus Genetics (NASDAQ: IRD) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- China Shenhua Energy (601088:CH) PT Raised to RMB53.60 at Citi
- Standard Chartered Plc. (2888:HK) (SCBFF) PT Raised to GBP248.40 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
